Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Massachusetts for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Massachusetts only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Massachusetts (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Shilpa Desai (NPI 1104112879)

Field	Value
Entity Type	Individual
Organization	Shilpa Desai
Address	300 Mount Auburn St
City	Cambridge
State	MA
ZIP	02138
Taxonomy	Ophthalmology Physician
NPI Enumerated	June 21, 2011

Payer Source	Total Paid
Medicare	$1.6M
Medicaid	$0

Key Findings

This provider’s billing is effectively single‑payer: total Medicare revenue is $1.6M and there is no Medicaid billing on file. The dataset also reports that the top 3 Medicare codes by revenue account for 90.6% of this provider’s total Medicare revenue, indicating concentrated reliance on a few services and drugs.

Clinical focus and service line are centered on intravitreal pharmacotherapy and retina diagnostics. The largest revenue code is J0178 (injection, aflibercept) with $1.2M revenue (73.5% of Medicare revenue), supported by procedure 67028 (intravitreal injection) with $100.5K (6.3%) and high-volume retinal imaging 92134 with $53.8K (3.4%), together describing an operation that delivers frequent anti‑VEGF injections plus diagnostic OCT imaging.

Revenue concentration is pronounced: J0178 ($1.2M, 73.5%), J2777 ($172.3K, 10.8%), and 67028 ($100.5K, 6.3%) together account for 90.6% of Medicare revenue. That mix implies most Medicare dollars come from a narrow set of retina drugs and the injection procedure rather than a broad portfolio of evaluation-and-management or surgical codes.

Competitive standing on the primary drug J0178 is mid-to-upper nationally: J0178 ranks #682 of 3204 providers (79th percentile) and is described as typical, unremarkable volume for this code, meaning the provider sees significant aflibercept use but is not a national outlier or dominant center.

Faricimab (J2777) volumes are lower relative to national peers: J2777 ranks #1399 of 2039 (31th percentile) and is characterized as typical, unremarkable volume, suggesting adoption of newer agents is present but not a major revenue driver compared with aflibercept. The intravitreal injection procedure 67028 ranks #1365 of 4255 (68th percentile), indicating a modestly above-typical procedural throughput consistent with a retina-focused injection practice.

Several non-drug codes show above-typical imaging and follow-up activity: 92134 (OCT imaging) is 1.7K claims and $53.8K (3.4%) and ranks in the 95th percentile as notably above typical national volume, while 92014 (established comprehensive eye exam) ranks in the 89th percentile. These patterns reinforce that the practice pairs frequent injections with high diagnostic imaging and ongoing established-patient management.

Operational implications of the concentration are material: with most Medicare revenue tied to a small set of high-cost injection codes and associated procedures, reimbursement changes or shifts in preferred agents could materially affect revenue. The lack of Medicaid billing also means the provider’s public-payer exposure is concentrated in Medicare, so payer-mix shifts would likely come from commercial or Medicare policy changes rather than state Medicaid.

The provider has an established billing history, with NPI enumeration dated 2011-06-21 (~15 years ago), indicating a stable presence in the market and sufficient time to build referral relationships and a repeat injection/imaging patient base. That tenure, combined with high OCT and injection volumes, is consistent with a sustained retina-focused ambulatory practice rather than a recently established or episodic operator.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

11 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,700	$690	$1.2M
J2777	Injection, faricimab‑svoa, 0.1 mg	5,940	$30	$172.3K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,020	$100	$100.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	650	$90	$57.6K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,740	$30	$53.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	400	$70	$27.1K
92004	The provider performs a comprehensive level ophthalmological evaluation of a new patient and initiates a diagnostic and treatment program for one or more visits.	50	$90	$4.8K
J9035	Injection, bevacizumab, 10 mg	90	$50	$4.7K
92250	Code 92250 describes the taking of fundus photographs, that is, photographs of the posterior segment of the inner aspect of the eye, to document alterations in the optic nerve head, retinal vessels,…	80	$20	$1.5K
76512	The provider uses B–scan ultrasound imaging, with or without a non–qualitative A–scan superimposed, to examine the intraocular and orbital structures.	50	$30	$1.3K

Showing 1–10 of 11

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 11 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Massachusetts Distribution

Shilpa Desai — 0 of 11 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Massachusetts

Full comparison — all codes billed, vs. state median

11 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	90	790	$690	$826.5K
J2777	30	50	7,080	$30	$343.1K
67028	36	120	570	$100	$80.7K
92014	176	1,070	160	$90	$30.1K
J9035	60	80	250	$50	$19.7K
92134	38	670	70	$30	$10.6K
99213	1,084	13,700	70	$60	$8.8K
92004	373	890	40	$100	$6.3K
92250	236	570	60	$30	$3.1K
76512	12	60	40	$30	$1.8K

Showing 1–10 of 11

Related Providers

Other providers that share a Tax Identification Number (TIN) with Shilpa Desai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Cambridge Public Health Commission	MA	General Acute Care Hospital	$0	$352.9M
Tufts Medical Center, Inc.	MA	General Acute Care Hospital	$0	$164.6M
Cambridge Public Health Commission	MA	Clinic/Center	$0	$19.8M
Cambridge Public Health Commission	MA	General Acute Care Hospital	$0	$9M
David Reed	MA	Retina Specialist (Ophthalmology) Physician	$7.7M	$0
Torsten Wiegand	MA	Retina Specialist (Ophthalmology) Physician	$7.6M	$0
Anubha Sacheti	MA	General Practice Dentistry	$0	$7M
Chirag Shah	MA	Retina Specialist (Ophthalmology) Physician	$5M	$0
Roger Goldberg	CA	Retina Specialist (Ophthalmology) Physician	$4.6M	$0
Miriam Englander-paschalis Ilios	MA	Retina Specialist (Ophthalmology) Physician	$4.5M	$0

Nearby Providers

Other providers in the same ZIP code as Shilpa Desai, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mount Auburn Hospital	MA	General Acute Care Hospital	$0	$28M
Professional Ambulance & Oxygen Svc, Inc	MA	Land Ambulance	$2.8M	$13.4M
Cambridge Medical Supply Inc	MA	Durable Medical Equipment & Medical Supplies	$0	$5.6M
Howard Ying	MA	Ophthalmology Physician	$2.5M	$149K
Christopher Robinson	MA	Ophthalmology Physician	$1M	$0
Katherine Wang	MA	Neurological Surgery Physician	$489.5K	$0
Nelson Aweh	MA	Internal Medicine Physician	$425.3K	$0
Kyle Pond	MA	Cardiovascular Disease Physician	$366.6K	$1.2K
Jeffrey Leavitt	MA	Cardiovascular Disease Physician	$356.8K	$370
Charles Barsam	MA	Ophthalmology Physician	$335.4K	$0

Shilpa Desai — Billing Profile & Reimbursement Data

Sign up for Shilpa Desai — Billing Profile & Reimbursement Data policy alerts

Shilpa Desai — Billing Profile & Reimbursement Data

Sign up for Shilpa Desai — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References